Researchers are exploring the use of biomimetic nanoparticles to enhance cell pyroptosis, a form of cell death, in the treatment of melanoma. This approach is being investigated as a potential strategy for chemo-immunotherapy, and similar techniques are also being studied for the treatment of other types of cancer, including breast cancer. The use of nanoparticles to modulate immune cells and induce regulated cell death is seen as a promising area of research for cancer immunotherapy.